Δ8-Tetrahydrocannabinoquinone
Δ8-Tetrahydrocannabinoquinone (HU-336) is a potent antiangiogenic agent. Δ8-Tetrahydrocannabinoquinone inhibits angiogenesis by directly inducing apoptosis of vascular endothelial cells without changing the expression of pro- and antiangiogenic cytokines and receptors. Δ8-Tetrahydrocannabinoquinone is highly effective against tumor xenografts in nude mice[1].
Product Specifications
CAS Number
19542-59-7
Product Name Alternative
HU-336; Δ8-THCQ
UNSPSC
12352005
Target
Apoptosis
Related Pathways
Apoptosis
Field of Research
Cancer; Cardiovascular Disease
Smiles
O=C1C2=C(C(C(CCCCC)=C1)=O)OC(C)(C)[C@@]3([H])[C@@]2([H])CC(C)=CC3
Molecular Formula
C21H28O3
Molecular Weight
328.45
References & Citations
[1]Kogan NM, et al. A cannabinoid quinone inhibits angiogenesis by targeting vascular endothelial cells. Mol Pharmacol. 2006 Jul;70 (1) :51-9.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Fibronectin (Fn-3), CF405S conjugate, 0.1mg/mL
CD63 (MX-49.129.5), CF594 conjugate, 0.1mg/mL
Fibronectin (HFN7.1), CF740 conjugate, 0.1mg/mL
CD106 / VCAM1 (B-K9), CF568 conjugate, 0.1mg/mL
Human Lambda Light Chain (LcN-2 + ICO-106), CF647 conjugate, 0.1mg/mL
